Related Experiment Video
Updated: May 26, 2025

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Maria Apostolopoulou1,2,3, Vaia Lambadiari4, Michael Roden1,2,3
1Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University, 40225 Düsseldorf, Germany.
People with type 1 diabetes (T1D) often experience insulin resistance, not just beta-cell failure. This review explores T1D insulin resistance mechanisms, clinical features, and therapeutic targets for better glucose control.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Immunology
Background:
- Type 1 diabetes (T1D) is typically characterized by beta-cell failure.
- However, insulin resistance frequently coexists in individuals with T1D.
- The interplay between autoimmune and metabolic factors contributes to T1D pathophysiology.
Purpose of the Study:
- To review the mechanisms, clinical features, and therapeutic relevance of insulin resistance in T1D.
- To highlight the distinct phenotype of insulin resistance in T1D compared to type 2 diabetes.
- To discuss the role of insulin treatment and other factors in T1D insulin resistance.
Main Methods:
- Focus on human studies utilizing gold-standard techniques, primarily the euglycemic-hyperinsulinemic clamp.
- Analysis of pathophysiology involving metabolic and autoimmune factors.
- Review of clinical features and progression of tissue-specific insulin resistance in T1D.
Main Results:
- Insulin resistance in T1D can be tissue-specific, developing early and persisting.
- Pathophysiology is complex, involving synergistic metabolic and autoimmune factors.
- Insulin treatment, lifestyle factors, and glucolipotoxicity contribute to insulin resistance, but may not fully explain the T1D phenotype.
Conclusions:
- Insulin resistance is a significant, treatable component of T1D.
- Continuous subcutaneous insulin infusion may improve insulin resistance compared to multiple daily injections.
- Emerging therapies show promise for improving insulin resistance in T1D, but cost and off-label use limit current application.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: The Receptor and Signaling Pathways
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational